Get started
Work

Selective killing of malignant B cells using T cells redirected against malignancy variant receptor

Year: 2014
Type: article
Abstract: Meeting abstracts Advances in gene-transfer system and in-depth understanding of immune mechanism have made the immunotherapy a powerful tool for fighting against cancers. Recent studies demonstrated a therapeutic potential of T cells with chimeric antigen receptor (CAR) targeting CD19 in
DOI: 10.1186/2051-1426-2-s3-p16
Authors: Chungyong Han, Sujung Sim, Kwang Hui Kim, Don Gil Lee, Ho Sik Oh, Sang Hyun Park, Sunhee Hwang, Won Young Kim, Sangeun Lee, Young Ho Kim, Beom Kyu Choi, Carl June, Byoung Se Kwon
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W1999609343
FWCI:
Cites:
Cited by:
Related to: 10